News Sentiment

GOSS sentiment intelligence

Gossamer Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 46 Balanced news tone 65 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.17 Week of 10 Jul 2026
Weighted tone 46/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

73/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.0% over one week, +4.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Gossamer Bio (NASDAQ: GOSS) wins approval to boost authorized shares to 4.0B

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 73/100 classification
One-week reaction -2.0% Price reacting lower
Trend fit Trend inactive 4.8% over four weeks
Fair value -86.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 40
Negative 17

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Stock Titan 9
TradingView 6
ACCESS Newswire 4
simplywall.st 4
Business Wire 3
Quartr 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 22
Regulatory and legal 8
Analyst action 8
Balance sheet 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 65